RBP4 as a Biomarker for Metabolic Diseases

We are excited to announce that at Icosagen, we now offer high-quality RBP4 antibodies and antigens!

Retinol-binding protein 4, or RBP4, is a crucial transporter that carries vitamin A from the liver to the periphery. Vitamin A is essential for a variety of biological processes, including vision, immune function, and cell growth and differentiation. RBP4 has great potential as a biomarker in the diagnostics field, especially in diagnosing metabolic diseases. It supports the identification of a broad range of disorders, including obesity, insulin resistance, metabolic syndrome, type 2 diabetes, nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver (NAFL), cardiovascular diseases, and more.

We have carefully developed and validated our RBP4 antibodies to ensure high sensitivity and specificity for RBP4 detection. We have four clones available - 6C2, 10G3, 11A6, 14D5. Each of the clones has been extensively tested and shown to have excellent performance.

With our RBP4 antibodies as a biomarker, you can accurately identify patients who are at risk of these metabolic diseases, allowing for earlier intervention and better patient outcomes. In addition to our antibodies, we offer a range of RBP4 antigens.

To order our RBP4 antibodies and antigens, visit our website or contact us directly at sales@icosagen.com for more information.

Stay up to date with the latest news and developments by following Icosagen Diagnostics on LinkedIn.